EFFECTISAN FOR DISINFECTION OF OBJECTS OF VETERINARY SUPERVISION

The article provides information about the effectiveness of the drug is Effectisan in the laboratory. As a result of the conducted researches it is established that the tested preparation possesses a certain high antimicrobial activity. The drug (in vitro) is effective at concentrations from 0.2 to 1.0% against E. coli (pcs 1257), St. aureus (pcs 209-P), Mycobacterium B-5, Bac. cereus (pcs 96). With wet disinfection at a concentration of 0.5% and a consumption rate of 350 ml/m2, the drug has a pronounced disinfection activity against surfaces made of various materials, the quality control of disinfection in which is carried out by the presence or absence of growth in the washouts of test cultures E. coli, S. aureus. At a concentration of 2.0% and the rate of 350 ml/m2 Effectisan has a pronounced disinfectant activity during processing objects and for quality control of disinfection by selection of cultures of Mycobacterium tuberculosis (pcs-5).

Current EpidemiologicaL Situation on Tularemia in the Northwestern Federal District of Russia

Relevance. In Russia every year are registred 100 or more cases of tularemia, with about 70% of them in the Central, Northwest and Siberian federal districts. Goal. Assessment of the current epidemiological situation on tularemia in the North-West Federal district (NWFD). Materials and methods. By means of a MapInfo Professional-10,5 GIS-package information on selection of cultures of the activator of a tularemia and the recorded incidence was transformed to the database on the basis of which GIS layers were created. Definition of geographical coordinates of places of isolation of cultures of a tulyaremiyny microbe from biological objects in the territory of the NWFD is carried out by means of the GoogleEarth program. Results. In 2001 - 2015 in NWFD incidence observed in all regions of the district, except Novgorod and Pskov regions. But the analysis of incidence of a tularemia allowed to reveal the sick people who infected in the territory of these regions that means there regions is endemic of tularemia. There remains a strong tendency to increase the incidence of tularemia urban population.The lack of permanent monitoring of natural eyes of tularemia in some regions of the district, does not allow to trace the development of epizootic process and to assess the intensity and magnitude of epizootics. As a result, activation of natural foci of tularemia is not noted, which increases the risk of human infection in these areas. Conclusions. Insufficient or complete lack of vaccination of people against tularemia living in areas enzootic for this infection may lead to complication of the epidemiological situation.

A new hematopoietic cell line, KMT-2, having human interleukin-3 receptors

A novel human cell line, KMT-2, from umbilical cord blood cells was established based on the selection of cultures in the presence of recombinant human interleukin-3 (IL-3) and the sorting of cells with anti-My 10 antibody. Morphologic and cytochemical studies (peroxidase negative, Sudan-black negative, chloroacetate esterase negative, PAS positive, nonspecific esterase positive) and phenotyping (HLA-DR, My7 = CD13, My9 = CD33, My10 = CD34, MCS-2, LeuM1 positive, glycophorin A negative, and P2 negative) suggest that the KMT-2 cells are myelomonocytic cells, probably of immature progenitor origin. Besides IL-3, granulocyte-macrophage colony-stimulating factor supported the growth of the KMT-2 cells, but IL-1 alpha, IL-2, IL-4, IL-5, and erythropoietin did not. IL-6 showed only slight activity. Binding studies with 125I-labeled recombinant human (rh) IL-3 indicated that IL- 3 bound to a single class of high affinity receptors (approximately 4,000 receptors/cell) on KMT-2 cells with a kd of approximately 200 pmol/L. The chemical cross-linking assay demonstrated that radiolabeled hIL-3 bound three molecules with molecular masses of 170, 130, and 70 Kd. Present data suggest that the newly established human cell line will be a valuable tool for the biologic assay of hIL-3, and a model for biochemical studies of IL-3 receptors.

A new hematopoietic cell line, KMT-2, having human interleukin-3 receptors

A novel human cell line, KMT-2, from umbilical cord blood cells was established based on the selection of cultures in the presence of recombinant human interleukin-3 (IL-3) and the sorting of cells with anti-My 10 antibody. Morphologic and cytochemical studies (peroxidase negative, Sudan-black negative, chloroacetate esterase negative, PAS positive, nonspecific esterase positive) and phenotyping (HLA-DR, My7 = CD13, My9 = CD33, My10 = CD34, MCS-2, LeuM1 positive, glycophorin A negative, and P2 negative) suggest that the KMT-2 cells are myelomonocytic cells, probably of immature progenitor origin. Besides IL-3, granulocyte-macrophage colony-stimulating factor supported the growth of the KMT-2 cells, but IL-1 alpha, IL-2, IL-4, IL-5, and erythropoietin did not. IL-6 showed only slight activity. Binding studies with 125I-labeled recombinant human (rh) IL-3 indicated that IL- 3 bound to a single class of high affinity receptors (approximately 4,000 receptors/cell) on KMT-2 cells with a kd of approximately 200 pmol/L. The chemical cross-linking assay demonstrated that radiolabeled hIL-3 bound three molecules with molecular masses of 170, 130, and 70 Kd. Present data suggest that the newly established human cell line will be a valuable tool for the biologic assay of hIL-3, and a model for biochemical studies of IL-3 receptors.

373. Inhibitory strains of lactic streptococci and their significance in the selection of cultures for starter

1. Inhibitory strains of lactic streptococci have been encountered amongst strains of Str. cremoris isolated from starter and amongst strains of Str. lactis, isolated from sour milk, which had otherwise been regarded as suitable for cheesemaking.2. Methods are described for determining the concentration of inhibitory substance produced and the effect of these inhibitory strains on a wide selection of lactic streptococci.3. The significance of the presence of strains of lactic streptococci having inhibitory properties, if incorporated in starters, particularly when the strains are prepared separately and mixed in the vat, is discussed. Recommendations for the exclusion of inhibitory strains from such starter mixtures are made.